Women & Infants Hospital

Oncology & Cancer

Chemoresponse assay helps boost ovarian cancer survival

This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.

Health

Active duty military women may have higher STI risk

As the number of women in the military increases, so does the need for improved gynecologic care. Military women may be more likely to engage in high-risk sexual practices, be less likely to consistently use barrier contraception, ...

Obstetrics & gynaecology

Women over 40 still need effective contraception, research says

Women reaching the age of 40 tend to be less vigilant about birth control because they think the risk of pregnancy is low – or that birth control can cause health problems - but a review of the evidence by a team that includes ...

Psychology & Psychiatry

Study finds faults in proposed mental disorder diagnosis

A much anticipated addition to the revised Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5) is questionable according to research findings. The newly revised DSM-5, the first alterations since it ...

Obstetrics & gynaecology

Reproductive coercion, intimate partner violence prevalent

Enough women experience reproductive coercion – male behavior to control contraception and pregnancy outcomes – that a research team now recommends health care providers address the subjects with their patients and tailor ...

Obstetrics & gynaecology

Dr. Dwight Rouse addresses rapid increase in cesarean birth rates

In 2011, one in three pregnant women in the U.S. delivered babies by cesarean delivery. While cesarean delivery may be life-saving for the mother, the baby or both, the rapid increase in cesarean birth rates since 1996 without ...

Oncology & Cancer

Researcher contributes to debate on breast cancer gene screening

There has been much recent debate on the benefits and risks of screening for breast cancer using BRCA1 and BRCA2 mutations in the general adult population. With an estimated 235,000 new breast cancer diagnoses each year in ...

page 2 from 3